Problem statement: Answer the MCQ question.
Query: Which compound exhibits a -36.856% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a: CC1CCC(NC(=O)c2cc(S(=O)(=O)N3CCCCC3)ccc2N2CCOCC2)CC1
b: COCCn1c(SCC(=O)Nc2cccc(S(N)(=O)=O)c2)nc2cc(Cl)ccc2c1=O
c: CCOc1ccc(/C=N/Nc2cc(C)nc(N3CCOCC3)n2)cc1
d: CCC1=C(OC(=O)N(CC)CC)N2C(=O)OC(=NCCc3c[nH]c4ccccc34)[C@]2(Cc2ccccc2)[C@H]2C1=CC[C@H]1C(=O)N(CC)C(=O)[C@H]12
Answer: a. CC1CCC(NC(=O)c2cc(S(=O)(=O)N3CCCCC3)ccc2N2CCOCC2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCC(NC(=O)c2cc(S(=O)(=O)N3CCCCC3)ccc2N2CCOCC2)CC1
CC1CCC(NC(=O)c2cc(S(=O)(=O)N3CCCCC3)ccc2N2CCOCC2)CC1
N-(4-methylcyclohexyl)-2-morpholin-4-yl-5-piperidin-1-ylsulfonylbenzamide